title: Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.
authors.affiliation: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia.
authors.forename: Don E
authors.initials: DE
authors.lastname: Smith
authors.forename: Andrew
authors.initials: A
authors.lastname: Carr
authors.forename: Matthew
authors.initials: M
authors.lastname: Law
authors.forename: Allison
authors.initials: A
authors.lastname: Martin
authors.forename: Jeff
authors.initials: J
authors.lastname: Hudson
authors.forename: Jennifer
authors.initials: J
authors.lastname: Hoy
authors.forename: David A
authors.initials: DA
authors.lastname: Cooper
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018119:Stavudine / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome; D013936:Thymidine / Q000031:analogs & derivatives*; D015215:Zidovudine / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D015215:Zidovudine; D018119:Stavudine; D013936:Thymidine